Discrimination of cytosolic self and non-self RNA by RIG-I-like receptors

Journal of Biological Chemistry

Volumn 292, Issue 22, 2017, Pages 9000-9009

  Lässig, Charlotte ^a   Hopfner, Karl Peter ^a,b,c  

^a UNIVERSITY OF MUNICH   (Germany)

^b Munich Center for Integrated Protein Science   (Germany)

^c Gene Center   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL ACTIVATION; RNA;

ANTIVIRAL RESPONSE; AUTOIMMUNE DISEASE; CYTOSOLIC; HELICASES; INNATE IMMUNES; MOLECULAR CHARACTERIZATION;

NUCLEIC ACIDS;

ADENOSINE TRIPHOSPHATASE; HELICASE; RIG I LIKE RECEPTOR; RNA; UNCLASSIFIED DRUG; RETINOIC ACID INDUCIBLE PROTEIN I;

ARTICLE; AUTOIMMUNE DISEASE; CYTOSOL; ENZYME ACTIVITY; HUMAN; INNATE IMMUNITY; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; ANIMAL; IMMUNOLOGY;

ANIMALS; AUTOIMMUNE DISEASES; DEAD BOX PROTEIN 58; HUMANS; IMMUNITY, INNATE; RNA;

EID: 85020240331     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.R117.788398     Document Type: Article

References (100)

1. Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., Taira, K., Akira, S., and Fujita, T. (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5, 730-737
2. Yoneyama, M., Kikuchi, M., Matsumoto, K., Imaizumi, T., Miyagishi, M., Taira, K., Foy, E., Loo, Y.-M., Gale, M., Jr., Akira, S., Yonehara, S., Kato, A., and Fujita, T. (2005) Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 175, 2851-2858
3. Singleton, M. R., Dillingham, M. S., and Wigley, D. B. (2007) Structure and mechanism of helicases and nucleic acid translocases. Annu. Rev. Biochem. 76, 23-50
4. Schlee, M., Roth, A., Hornung, V., Hagmann, C. A., Wimmenauer, V., Barchet, W., Coch, C., Janke, M., Mihailovic, A., Wardle, G., Juranek, S., Kato, H., Kawai, T., Poeck, H., Fitzgerald, K. A., et al. (2009) Recognition of 5-triphosphate by RIG-I helicase requires short blunt doublestranded RNA as contained in panhandle of negative-strand virus. Immunity 31, 25-34
5. Schmidt, A., Schwerd, T., Hamm, W., Hellmuth, J. C., Cui, S., Wenzel, M., Hoffmann, F. S., Michallet, M.-C., Besch, R., Hopfner, K.-P., Endres, S., and Rothenfusser, S. (2009) 5-Triphosphate RNA requires basepaired structures to activate antiviral signaling via RIG-I. Proc. Natl. Acad. Sci. U.S.A. 106, 12067-12072
6. Goubau, D., Schlee, M., Deddouche, S., Pruijssers, A. J., Zillinger, T., Goldeck, M., Schuberth, C., Van der Veen, A. G., Fujimura, T., Rehwinkel, J., Iskarpatyoti, J. A., Barchet, W., Ludwig, J., Dermody, T. S., Hartmann, G., and Reis e Sousa, C. (2014) Antiviral immunity via RIG-Imediated recognition of RNA bearing 5-diphosphates. Nature 514, 372-375
7. Weber, M., Gawanbacht, A., Habjan, M., Rang, A., Borner, C., Schmidt, A. M., Veitinger, S., Jacob, R., Devignot, S., Kochs, G., García-Sastre, A., and Weber, F. (2013) Incoming RNA virus nucleocapsids containing a 5-triphosphorylated genome activate RIG-I and antiviral signaling. Cell Host Microbe 13, 336-346
8. Baum, A., Sachidanandam, R., and García-Sastre, A. (2010) Preference of RIG-I for short viral RNA molecules in infected cells revealed by nextgeneration sequencing. Proc. Natl. Acad. Sci. U.S.A. 107, 16303-16308
9. Runge, S., Sparrer, K. M., Lässig, C., Hembach, K., Baum, A., García- Sastre, A., Söding, J., Conzelmann, K.-K., and Hopfner, K.-P. (2014) In vivo ligands of MDA5 and RIG-I in measles virus-infected cells. PLOS Pathog. 10, e1004081
10. Saito, T., Owen, D. M., Jiang, F., Marcotrigiano, J., and Gale, M., Jr. (2008) Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454, 523-527
11. Zhang, H.-X., Liu, Z.-X., Sun, Y.-P., Zhu, J., Lu, S.-Y., Liu, X.-S., Huang, Q.-H., Xie, Y.-Y., Zhu, H.-B., Dang, S.-Y., Chend, H.-F., Zheng, G.-Y., Li, Y.-X., Kuang, Y., Fei, J., et al. (2013) Rig-I regulates NF-B activity through binding to Nf-B1 3-UTR mRNA. Proc. Natl. Acad. Sci. U.S.A. 110, 6459-6464
12. Sanchez David, R. Y., Combredet, C., Sismeiro, O., Dillies, M.-A., Jagla, B., Coppée, J.-Y., Mura, M., Guerbois Galla, M., Despres, P., Tangy, F., and Komarova, A. V. (2016) Comparative analysis of viral RNA signatures on different RIG-I-like receptors. Elife 5, e11275
13. Malathi, K., Dong, B., Gale, M., Jr., and Silverman, R. H. (2007) Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448, 816-819
14. Malathi, K., Saito, T., Crochet, N., Barton, D. J., Gale, M., Jr., and Silverman, R. H. (2010) RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP. RNA 16, 2108-2119
15. Kato, H., Takeuchi, O., Mikamo-Satoh, E., Hirai, R., Kawai, T., Matsushita, K., Hiiragi, A., Dermody, T. S., Fujita, T., and Akira, S. (2008) Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J. Exp. Med. 205, 1601-1610
16. Pichlmair, A., Schulz, O., Tan, C.-P., Rehwinkel, J., Kato, H., Takeuchi, O., Akira, S., Way, M., Schiavo, G., and Reis e Sousa, C. (2009) Activation of MDA5 requires higher-order RNA structures generated during virus infection. J. Virol. 83, 10761-10769
17. Peisley, A., Lin, C., Wu, B., Orme-Johnson, M., Liu, M., Walz, T., and Hur, S. (2011) Cooperative assembly and dynamic disassembly of MDA5 filaments for viral dsRNA recognition. Proc. Natl. Acad. Sci. U.S.A. 108, 21010-21015
18. Feng, Q., Hato, S. V., Langereis, M. A., Zoll, J., Virgen-Slane, R., Peisley, A., Hur, S., Semler, B. L., van Rij, R. P., and van Kuppeveld, F. J. (2012) MDA5 detects the double-stranded RNA replicative form in picornavirus- infected cells. Cell Rep. 2, 1187-1196
19. Li, X., Ranjith-Kumar, C. T., Brooks, M. T., Dharmaiah, S., Herr, A. B., Kao, C., and Li, P. (2009) The RIG-I-like receptor LGP2 recognizes the termini of double-stranded RNA. J. Biol. Chem. 284, 13881-13891
20. Pippig, D. A., Hellmuth, J. C., Cui, S., Kirchhofer, A., Lammens, K., Lammens, A., Schmidt, A., Rothenfusser, S., and Hopfner, K.-P. (2009) The regulatory domain of the RIG-I family ATPase LGP2 senses doublestranded RNA. Nucleic Acids Res. 37, 2014-2025
21. Uchikawa, E., Lethier, M., Malet, H., Brunel, J., Gerlier, D., and Cusack, S. (2016) Structural analysis of dsRNA binding to anti-viral pattern recognition receptors LGP2 and MDA5. Mol. Cell 62, 586-602
22. Childs, K. S., Randall, R. E., and Goodbourn, S. (2013) LGP2 plays a critical role in sensitizing mda-5 to activation by double-stranded RNA. PLoS ONE 8, e64202
23. Bruns, A. M., Leser, G. P., Lamb, R. A., and Horvath, C. M. (2014) The innate immune sensor LGP2 activates antiviral signaling by regulating MDA5-RNA interaction and filament assembly. Mol. Cell 55, 771-781
24. Luo, D., Ding, S. C., Vela, A., Kohlway, A., Lindenbach, B. D., and Pyle, A. M. (2011) Structural insights intoRNArecognition by RIG-I. Cell 147, 409-422
25. Kowalinski, E., Lunardi, T., McCarthy, A. A., Louber, J., Brunel, J., Grigorov, B., Gerlier, D., and Cusack, S. (2011) Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 147, 423-435
26. Jiang, F., Ramanathan, A., Miller, M. T., Tang, G.-Q., Gale, M., Jr., Patel, S. S., and Marcotrigiano, J. (2011) Structural basis of RNA recognition and activation by innate immune receptor RIG-I. Nature 479, 423-427
27. Wu, B., Peisley, A., Richards, C., Yao, H., Zeng, X., Lin, C., Chu, F., Walz, T., and Hur, S. (2013) Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell 152, 276-289
28. Chamberlain, P. P., Lopez-Girona, A., Miller, K., Carmel, G., Pagarigan, B., Chie-Leon, B., Rychak, E., Corral, L. G., Ren, Y. J., Wang, M., Riley, M., Delker, S. L., Ito, T., Ando, H., Mori, T., et al. (2014) Structure of the human Cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogs. Nat. Struct. Mol. Biol. 21, 803-809
29. Ito, T., Ando, H., Suzuki, T., Ogura, T., Hotta, K., Imamura, Y., Yamaguchi, Y., and Handa, H. (2010) Identification of a primary target of thalidomide teratogenicity. Science 327, 1345-1350
30. Takahasi, K., Kumeta, H., Tsuduki, N., Narita, R., Shigemoto, T., Hirai, R., Yoneyama, M., Horiuchi, M., Ogura, K., Fujita, T., and Inagaki, F. (2009) Solution structures of cytosolic RNA sensor MDA5 and LGP2 C-terminal domains identification of the RNA recognition loop in RIG-I-like receptors. J. Biol. Chem. 284, 17465-17474
31. Gack, M. U., Shin, Y. C., Joo, C.-H., Urano, T., Liang, C., Sun, L., Takeuchi, O., Akira, S., Chen, Z., Inoue, S., and Jung, J. U. (2007) TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446, 916-920
32. Zeng, W., Sun, L., Jiang, X., Chen, X., Hou, F., Adhikari, A., Xu, M., and Chen, Z. J. (2010) Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 141, 315-330
33. Jiang, X., Kinch, L. N., Brautigam, C. A., Chen, X., Du, F., Grishin, N. V., and Chen, Z. J. (2012) Ubiquitin-induced oligomerization of the RNA sensors RIG-I and MDA5 activates antiviral innate immune response. Immunity 36, 959-973
34. Peisley, A., Wu, B., Xu, H., Chen, Z. J., and Hur, S. (2014) Structural basis for ubiquitin-mediated antiviral signal activation by RIG-I. Nature 509, 110-114
35. Seth, R. B., Sun, L., Ea, C.-K., and Chen, Z. J. (2005) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-B and IRF3. Cell 122, 669-682
36. Dixit, E., Boulant, S., Zhang, Y., Lee, A. S., Odendall, C., Shum, B., Hacohen, N., Chen, Z. J., Whelan, S. P., Fransen, M., Nibert, M. L., Superti- Furga, G., and Kagan, J. C. (2010) Peroxisomes are signaling platforms for antiviral innate immunity. Cell 141, 668-681
37. Wu, B., Peisley, A., Tetrault, D., Li, Z., Egelman, E. H., Magor, K. E., Walz, T., Penczek, P. A., and Hur, S. (2014) Molecular imprinting as a signalactivation mechanism of the viral RNA sensor RIG-I. Mol. Cell 55, 511-523
38. Liu, S., Cai, X., Wu, J., Cong, Q., Chen, X., Li, T., Du, F., Ren, J., Wu, Y.-T., Grishin, N. V., and Chen, Z. J. (2015) Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 347, aaa2630
39. Devarkar, S. C., Wang, C., Miller, M. T., Ramanathan, A., Jiang, F., Khan, A. G., Patel, S. S., and Marcotrigiano, J. (2016) Structural basis for m7G recognition and 2-O-methyl discrimination in capped RNAs by the innate immune receptor RIG-I. Proc. Natl. Acad. Sci. U.S.A. 113, 596-601
40. Schuberth-Wagner, C., Ludwig, J., Bruder, A. K., Herzner, A.-M., Zillinger, T., Goldeck, M., Schmidt, T., Schmid-Burgk, J. L., Kerber, R., Wolter, S., Stümpel, J.-P., Roth, A., Bartok, E., Drosten, C., Coch, C., et al. (2015) A conserved histidine in the RNA sensor RIG-I controls immune tolerance to N1-2 O-methylated self-RNA. Immunity 43, 41-51
41. Züst, R., Cervantes-Barragan, L., Habjan, M., Maier, R., Neuman, B. W., Ziebuhr, J., Szretter, K. J., Baker, S. C., Barchet, W., Diamond, M. S., Siddell, S. G., Ludewig, B., and Thiel, V. (2011) Ribose 2-O-methylation provides a molecular signature for the distinction of self and non-self mRNAdependent on theRNAsensor Mda5. Nat. Immunol. 12, 137-143
42. Marques, J. T., Devosse, T., Wang, D., Zamanian-Daryoush, M., Serbinowski, P., Hartmann, R., Fujita, T., Behlke, M. A., and Williams, B. R. (2006) A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat. Biotechnol. 24, 559-565
43. Mannion, N. M., Greenwood, S. M., Young, R., Cox, S., Brindle, J., Read, D., Nellaker, C., Vesely, C., Ponting, C. P., McLaughlin, P. J., Jantsch, M. F., Dorin, J., Adams, I. R., Scadden, A. D., Ohman, M., Keegan, L. P., and O'Connell, M. A. (2014) The RNA-editing enzyme ADAR1 controls innate immune responses to RNA. Cell Rep. 9, 1482-1494
44. Liddicoat, B. J., Piskol, R., Chalk, A. M., Ramaswami, G., Higuchi, M., Hartner, J. C., Li, J. B., Seeburg, P. H., and Walkley, C. R. (2015) RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself. Science 349, 1115-1120
45. Mannion, N., Arieti, F., Gallo, A., Keegan, L. P., and O'Connell, M. A. (2015) New insights into the biological role of mammalian ADARs; the RNA editing proteins. Biomolecules 5, 2338-2362
46. Gack, M. U., Nistal-Villán, E., Inn, K.-S., García-Sastre, A., and Jung, J. U. (2010) Phosphorylation-mediated negative regulation of RIG-I antiviral activity. J. Virol. 84, 3220-3229
47. Maharaj, N. P., Wies, E., Stoll, A., and Gack, M. U. (2012) Conventional protein kinase C- (PKC-) and PKC- negatively regulate RIG-I antiviral signal transduction. J. Virol. 86, 1358-1371
48. Wies, E., Wang, M. K., Maharaj, N. P., Chen, K., Zhou, S., Finberg, R. W., and Gack, M. U. (2013) Dephosphorylation of the RNA sensors RIG-I and MDA5 by the phosphatase PP1 is essential for innate immune signaling. Immunity 38, 437-449
49. Ibsen, M. S., Gad, H. H., Andersen, L. L., Hornung, V., Julkunen, I., Sarkar, S. N., and Hartmann, R. (2015) Structural and functional analysis reveals that human OASL binds dsRNA to enhance RIG-I signaling. Nucleic Acids Res. 43, 5236-5248
50. Choi, S. J., Lee, H. C., Kim, J. H., Park, S. Y., Kim, T. H., Lee, W. K., Jang, D. J., Yoon, J. E., Choi, Y. I., Kim, S., Ma, J., Kim, C. J., Yao, T. P., Jung, J. U., Lee, J. Y., and Lee, J. S. (2016) HDAC6 regulates cellular viral RNA sensing by deacetylation of RIG-I. EMBO J. 35, 429-442
51. Bruns, A. M., Pollpeter, D., Hadizadeh, N., Myong, S., Marko, J. F., and Horvath, C. M. (2013) ATP hydrolysis enhances RNA recognition and antiviral signal transduction by the innate immune sensor, laboratory of genetics and physiology 2 (LGP2). J. Biol. Chem. 288, 938-946
52. Takahasi, K., Yoneyama, M., Nishihori, T., Hirai, R., Kumeta, H., Narita, R., Gale, M., Jr., Inagaki, F., and Fujita, T. (2008) Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol. Cell 29, 428-440
53. Gee, P., Chua, P. K., Gevorkyan, J., Klumpp, K., Najera, I., Swinney, D. C., and Deval, J. (2008) Essential role of the N-terminal domain in the regulation of RIG-I ATPase activity. J. Biol. Chem. 283, 9488-9496
54. Bamming, D., and Horvath, C. M. (2009) Regulation of signal transduction by enzymatically inactive antiviral RNA helicase proteins MDA5, RIG-I, and LGP2. J. Biol. Chem. 284, 9700-9712
55. Ramanathan, A., Devarkar, S. C., Jiang, F., Miller, M. T., Khan, A. G., Marcotrigiano, J., and Patel, S. S. (2016) The autoinhibitory CARD2- Hel2i Interface of RIG-I governs RNA selection. Nucleic Acids Res. 44, 896-909
56. Wang, Y., Ludwig, J., Schuberth, C., Goldeck, M., Schlee, M., Li, H., Juranek, S., Sheng, G., Micura, R., Tuschl, T., Hartmann, G., and Patel, D. J. (2010) Structural and functional insights into 5-ppp RNA pattern recognition by the innate immune receptor RIG-I. Nat. Struct. Mol. Biol. 17, 781-787
57. Vela, A., Fedorova, O., Ding, S. C., and Pyle, A. M. (2012) The thermodynamic basis for viral RNA detection by the RIG-I innate immune sensor. J. Biol. Chem. 287, 42564-42573
58. Anchisi, S., Guerra, J., and Garcin, D. (2015) RIG-I ATPase activity and discrimination of self-RNA versus non-self-RNA. MBio 6, e02349-02314
59. Louber, J., Brunel, J., Uchikawa, E., Cusack, S., and Gerlier, D. (2015) Kinetic discrimination of self/non-self RNA by the ATPase activity of RIG-I and MDA5. BMC Biol. 13, 54
60. Rawling, D. C., Fitzgerald, M. E., and Pyle, A. M. (2015) Establishing the role of ATP for the function of the RIG-I innate immune sensor. Elife 4, e09391
61. Lässig, C., Matheisl, S., Sparrer, K. M., de Oliveira Mann, C. C., Moldt, M., Patel, J. R., Goldeck, M., Hartmann, G., García-Sastre, A., Hornung, V., Conzelmann, K.-K., Beckmann, R., and Hopfner, K.-P. (2015) ATP hydrolysis by the viral RNA sensor RIG-I prevents unintentional recognition of self-RNA. Elife 4, e10859
62. Fitzgerald, M. E., Rawling, D. C., Potapova, O., Ren, X., Kohlway, A., and Pyle, A. M. (2017) Selective RNA targeting and regulated signaling by RIG-I is controlled by coordination of RNA and ATP binding. Nucleic Acids Res. 45, 1442-1454
63. Peisley, A., Wu, B., Yao, H., Walz, T., and Hur, S. (2013) RIG-I forms signaling-competentfilamentsinanATP-dependent, ubiquitin-independent manner. Mol. Cell 51, 573-583
64. Myong, S., Cui, S., Cornish, P. V., Kirchhofer, A., Gack, M. U., Jung, J. U., Hopfner, K.-P., and Ha, T. (2009) Cytosolic viral sensor RIG-I is a 5- triphosphate-dependent translocase on double-stranded RNA. Science 323, 1070-1074
65. Patel, J. R., Jain, A., Chou, Y. Y., Baum, A., Ha, T., and García-Sastre, A. (2013) ATPase-driven oligomerization of RIG-I on RNA allows optimal activation of type-I interferon. EMBO Rep. 14, 780-787
66. Yao, H., Dittmann, M., Peisley, A., Hoffmann, H.-H., Gilmore, R. H., Schmidt, T., Schmid-Burgk, J. L., Hornung, V., Rice, C. M., and Hur, S. (2015) ATP-dependent effector-like functions of RIG-I-like receptors. Mol. Cell 58, 541-548
67. Sato, S., Li, K., Kameyama, T., Hayashi, T., Ishida, Y., Murakami, S., Watanabe, T., Iijima, S., Sakurai, Y., Watashi, K., Tsutsumi, S., Sato, Y., Akita, H., Wakita, T., Rice, C. M., et al. (2015) The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus. Immunity 42, 123-132
68. Jang, M.-A., Kim, E. K., Now, H., Nguyen, N. T., Kim, W.-J., Yoo, J.-Y., Lee, J., Jeong, Y.-M., Kim, C.-H., Kim, O.-H., Sohn, S., Nam, S.-H., Hong, Y., Lee, Y. S., Chang, S.-A., et al. (2015) Mutations in DDX58, which encodes RIG-I, cause atypical Singleton-Merten syndrome. Am. J. Hum. Genet. 96, 266-274
69. Lee-Kirsch, M. A. (2017) The type I interferonopathies. Annu. Rev. Med. 68, 297-315
70. Aicardi, J., and Goutières, F. (1984) A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis. Ann. Neurol. 15, 49-54
71. Rice, G. I., del Toro Duany, Y., Jenkinson, E. M., Forte, G. M., Anderson, B. H., Ariaudo, G., Bader-Meunier, B., Baildam, E. M., Battini, R., Beresford, M. W., Casarano, M., Chouchane, M., Cimaz, R., Collins, A. E., Cordeiro, N. J., et al. (2014) Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat. Genet. 46, 503-509
72. Crow, Y. J., Chase, D. S., Lowenstein Schmidt, J., Szynkiewicz, M., Forte, G., Gornall, H. L., Oojageer, A., Anderson, B., Pizzino, A., and Helman, G. (2015) Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. Am. J. Med. Genet. 167A, 296-312
73. Oda, H., Nakagawa, K., Abe, J., Awaya, T., Funabiki, M., Hijikata, A., Nishikomori, R., Funatsuka, M., Ohshima, Y., Sugawara, Y., Yasumi, T., Kato, H., Shirai, T., Ohara, O., Fujita, T., and Heike, T. (2014) Aicardi- Goutieres syndrome is caused by IFIH1 mutations. Am. J. Hum. Genet. 95, 121-125
74. Ghodke-Puranik, Y., and Niewold, T. B. (2013) Genetics of the type I interferon pathway in systemic lupus erythematosus. Int. J. Clin. Rheumatol. 8, 657-669
75. Gateva, V., Sandling, J. K., Hom, G., Taylor, K. E., Chung, S. A., Sun, X., Ortmann, W., Kosoy, R., Ferreira, R. C., Nordmark, G., Svenungsson, E., Padyukov, L., Sturfelt, G., Jönsen, A., et al. (2009) A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat. Genet. 41, 1228-1233
76. Cunninghame Graham, D. S., Morris, D. L., Bhangale, T. R., Criswell, L. A., Syvänen, A.-C., Rönnblom, L., Behrens, T. W., Graham, R. R., and Vyse, T. J. (2011) Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet. 7, e1002341
77. Van Eyck, L., De Somer, L., Pombal, D., Bornschein, S., Frans, G., Humblet- Baron, S., Moens, L., de Zegher, F., Bossuyt, X., Wouters, C., and Liston, A. (2015) Brief report: IFIH1 mutation causes systemic lupus erythematosus with selective IgA deficiency. Arthritis Rheumatol. 67, 1592-1597
78. Molineros, J. E., Maiti, A. K., Sun, C., Looger, L. L., Han, S., Kim-Howard, X., Glenn, S., Adler, A., Kelly, J. A., Niewold, T. B., Gilkeson, G. S, . Brown, E. E., Alarcón, G. S., Edberg, J. C., Petri, M., et al. (2013) Admixture mapping in lupus identifies multiple functional variants within IFIH1 associated with apoptosis, inflammation, and autoantibody production. PLoS Genet. 9, e1003222
79. Yeung, W.-C., Rawlinson, W. D., and Craig, M. E. (2011) Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ 342, d35
80. Wang, J. P., Cerny, A., Asher, D. R., Kurt-Jones, E. A., Bronson, R. T., and Finberg, R. W. (2010) MDA5 and MAVS mediate type I interferon responses to coxsackie B virus. J. Virol. 84, 254-260
81. Smyth, D. J., Cooper, J. D., Bailey, R., Field, S., Burren, O., Smink, L. J., Guja, C., Ionescu-Tirgoviste, C., Widmer, B., Dunger, D. B., Savage, D. A., Walker, N. M., Clayton, D. G., and Todd, J. A. (2006) A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat. Genet. 38, 617-619
82. Nejentsev, S., Walker, N., Riches, D., Egholm, M., and Todd, J. A. (2009) Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 324, 387-389
83. Lincez, P. J., Shanina, I., and Horwitz, M. S. (2015) Reduced expression of the MDA5 gene IFIH1 prevents autoimmune diabetes. Diabetes 64, 2184-2193
84. Shigemoto, T., Kageyama, M., Hirai, R., Zheng, J., Yoneyama, M., and Fujita, T. (2009) Identification of loss of function mutations in human genes encoding RIG-I and MDA5 implications for resistance to type I diabetes. J. Biol. Chem. 284, 13348-13354
85. Rutsch, F., MacDougall, M., Lu, C., Buers, I., Mamaeva, O., Nitschke, Y., Rice, G. I., Erlandsen, H., Kehl, H. G., Thiele, H., Nürnberg, P., Höhne, W., Crow, Y. J., Feigenbaum, A., and Hennekam, R. C. (2015) A specific IFIH1 gain-of-function mutation causes Singleton-Merten syndrome. Am. J. Hum. Genet. 96, 275-282
86. Looney, B. M., Xia, C.-Q., Concannon, P., Ostrov, D. A., and Clare- Salzler, M. J. (2015) Effects of type 1 diabetes-associated IFIH1 polymorphisms on MDA5 function and expression. Curr. Diab. Rep. 15, 96
87. Zouk, H., Marchand, L., Li, Q., and Polychronakos, C. (2014) Functional characterization of the Thr946Ala SNP at the type 1 diabetes IFIH1 locus. Autoimmunity 47, 40-45
88. Zurawek, M., Fichna, M., Fichna, P., Skowronska, B., Dzikiewicz-Krawczyk, A., Januszkiewicz, D., and Nowak, J. (2015) Cumulative effect of IFIH1 variants and increased gene expression associated with type 1 diabetes. Diabetes Res. Clin. Pract. 107, 259-266
89. Funabiki, M., Kato, H., Miyachi, Y., Toki, H., Motegi, H., Inoue, M., Minowa, O., Yoshida, A., Deguchi, K., Sato, H., Ito, S., Shiroishi, T., Takeyasu, K., Noda, T., and Fujita, T. (2014) Autoimmune disorders associated with gain of function of the intracellular sensor MDA5. Immunity 40, 199-212
90. Gao, D., Yang, Y.-K., Wang, R.-P., Zhou, X., Diao, F.-C., Li, M.-D., Zhai, Z.-H., Jiang, Z.-F., and Chen, D.-Y. (2009) REUL is a novel E3 ubiquitin ligase and stimulator of retinoic-acid-inducible gene-I. PLOS ONE 4, e5760
91. Yan, J., Li, Q., Mao, A.-P., Hu, M.-M., and Shu, H.-B. (2014) TRIM4 modulates type I interferon induction and cellular antiviral response by targeting RIG-I for K63-linked ubiquitination. J. Mol. Cell Biol. 6, 154-163
92. Kuniyoshi, K., Takeuchi, O., Pandey, S., Satoh, T., Iwasaki, H., Akira, S., and Kawai, T. (2014) Pivotal role of RNA-binding E3 ubiquitin ligase MEX3C in RIG-I-mediated antiviral innate immunity. Proc. Natl. Acad. Sci. U.S.A. 111, 5646-5651
93. Mi, Z., Fu, J., Xiong, Y., and Tang, H. (2010) SUMOylation of RIG-I positively regulates the type I interferon signaling. Protein Cell 1, 275-283
94. Sun, Z., Ren, H., Liu, Y., Teeling, J. L., and Gu, J. (2011) Phosphorylation of RIG-I by casein kinase II inhibits its antiviral response. J. Virol. 85, 1036-1047
95. Zhang, X., Yu, H., Zhao, J., Li, X., Li, J., He, J., Xia, Z., and Zhao, J. (2016) IKK negatively regulates RIG-I via direct phosphorylation. J. Med. Virol. 88, 712-718
96. Oshiumi, H., Matsumoto, M., Hatakeyama, S., and Seya, T. (2009) Riplet/ RNF135, a RING finger protein, ubiquitinates RIG-I to promote interferon- induction during the early phase of viral infection. J. Biol. Chem. 284, 807-817
97. Zhang, M., Wu, X., Lee, A. J., Jin, W., Chang, M., Wright, A., Imaizumi, T., and Sun, S.-C. (2008) Regulation of I-B kinase-related kinases and antiviral responses by tumor suppressor CYLD. J. Biol. Chem. 283, 18621-18626
98. Friedman, C. S., O'Donnell, M. A., Legarda-Addison, D., Ng, A., Cárdenas, W. B., Yount, J. S., Moran, T. M., Basler, C. F., Komuro, A., Horvath, C. M., Xavier, R., and Ting, A. T. (2008) The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep. 9, 930-936
99. Cui, J., Song, Y., Li, Y., Zhu, Q., Tan, P., Qin, Y., Wang, H. Y., and Wang, R.-F. (2014) USP3 inhibits type I interferon signaling by deubiquitinating RIG-I-like receptors. Cell Res. 24, 400-416
100. Fan, Y., Mao, R., Yu, Y., Liu, S., Shi, Z., Cheng, J., Zhang, H., An, L., Zhao, Y., Xu, X., Chen, Z., Kogiso, M., Zhang, D., Zhang, H., Zhang, P., Jung, J. U., Li, X., Xu, G., and Yang, J. (2014) USP21 negatively regulates antiviral response by acting as a RIG-I deubiquitinase. J. Exp. Med. 211, 313-328